Hoth Therapeutics, Inc. Quarterly Debt-to-equity in % from Q3 2019 to Q4 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Hoth Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q3 2019 to Q4 2024.
  • Hoth Therapeutics, Inc. Debt-to-equity for the quarter ending December 31, 2024 was 9.04 %, a 31.1% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2024 9.04 -4.09 -31.1% Dec 31, 2024
Q3 2024 8.01 -8.49 -51.5% Sep 30, 2024
Q2 2024 9.27 -7.62 -45.1% Jun 30, 2024
Q1 2024 12.2 -2.1 -14.7% Mar 31, 2024
Q4 2023 13.1 -1.68 -11.3% Dec 31, 2023
Q3 2023 16.5 +4.6 +38.6% Sep 30, 2023
Q2 2023 16.9 +5 +42.1% Jun 30, 2023
Q1 2023 14.3 +2.87 +25.1% Mar 31, 2023
Q4 2022 14.8 +5.71 +62.7% Dec 31, 2022
Q3 2022 11.9 +2.85 +31.5% Sep 30, 2022
Q2 2022 11.9 +4.01 +50.9% Jun 30, 2022
Q1 2022 11.5 +3.83 +50.3% Mar 31, 2022
Q4 2021 9.11 -1.42 -13.5% Dec 31, 2021
Q3 2021 9.06 -1.89 -17.3% Sep 30, 2021
Q2 2021 7.88 -0.72 -8.38% Jun 30, 2021
Q1 2021 7.62 -0.19 -2.43% Mar 31, 2021
Q4 2020 10.5 +5.66 +116% Dec 31, 2020
Q3 2020 10.9 +5.94 +119% Sep 30, 2020
Q2 2020 8.6 Jun 30, 2020
Q1 2020 7.81 Mar 31, 2020
Q4 2019 4.87 Dec 31, 2019
Q3 2019 5 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.